Delivery Order SPE2DB22D1106-SPE2DB25FFBY2
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $1,362.40 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of September 29, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $2,863.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram quantity. Awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, this non-set-aside contract represents a small-value medical supply procurement. The work will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,119.18 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit on September 24, 2025, with an ultimate completion date of September 25, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award was performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's headquarters. This delivery order...
- AmerisourceBergen Drug Corp was awarded a delivery order contract on September 30, 2025, by the Department of Defense Medical Supply Chain for the supply of Proctofoam-HC 1%-1% Foam in a 10-gram quantity. The contract represents a non-competitive, firm fixed-price delivery order with a ceiling value of $1,020.46 and an ultimate completion date of October 1, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a $1,077.91 delivery order to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in a 10-gram quantity, with an ultimate completion date of May 7, 2025. This is a firm fixed price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product is being delivered to Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,724.56 on September 3, 2025, for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 4, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,764.08 by the Medical Supply Chain division of the Defense Logistics Agency on September 4, 2025, with an ultimate completion date of September 5, 2025. The contract involves the supply of Proctofoam-HC 1%-1% Foam in 10-gram units, a topical pharmaceutical product. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,671.67 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units. This competitive award, issued on June 18, 2025, with a completion date of June 20, 2025, carries firm fixed-price terms and requires performance at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement, indicating AmerisourceBergen competed against other vendors to secure...
- The Defense Logistics Agency awarded a delivery order valued at $1,228.60 to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Proctofoam-HC 1%-1% foam in 10-gram units. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for completion by July 11, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,643.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Proctofoam-HC 1%-1% foam in 10-gram units. The order, which is not set-aside, is scheduled for completion by September 26, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's existing prime indefinite delivery contract with DLA Troop...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFBY2Delivery Order
The Defense Logistics Agency awarded a $3,772.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units. This contract, awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a non-competitive, non-set-aside award. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999 and running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government entities. The company maintains an extensive portfolio of federal contract awards covering a wide spectrum of pharmaceutical products and medical supplies. This specific delivery order for Proctofoam-HC, a topical hemorrhoidal treatment, exemplifies the company's role in supplying specialized medical commodities to support military healthcare programs worldwide. The IDC vehicle under which this order was issued enables flexible procurement of brand-name and generic drugs, vaccines, and other medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 8/7/25 |